firm

  1. Ron Strider

    Cannabis Firm Hoban Law Sets Sights Abroad

    Hoban Law Group, a Denver-based firm focused on advising the emerging legal and medical cannabis industry, has announced plans to expand internationally, saying it would open four European and two Latin American offices by spring 2018. Pointing to a rapidly evolving marketplace for its...
  2. Ron Strider

    Pennsylvania Senator's Medical Marijuana Moonlighting Role

    Pennsylvania's 17-month-old Medical Marijuana Act prohibits elected and appointed public officials from having a financial stake in the burgeoning industry or working directly or indirectly for a cannabis company while serving in state government. Yet that did not prevent state Sen. Daylin...
  3. Katelyn Baker

    Denver Law Firm Taking DEA To Court Over New Rule For CBD And Hemp

    Last month, the Drug Enforcement Administration issued a new rule for marijuana extracts forcing any business using hemp or CBD products to register with the federal government using a new code – even if those products have under 0.3 percent THC. At the time, the Hoban Law Group said it would...
  4. Katelyn Baker

    NY: California Firm Buys Troubled Syracuse Medical Pot Dispensary

    Syracruse, N.Y. - Bloomfield Industries, the financially troubled operator of one of the medical marijuana dispensaries in the Syracuse area, is being purchased by a California company. MedMen, a California marijuana management and consulting firm, is buying Bloomfield, according to Politico...
  5. Katelyn Baker

    Colorado's Cannabis Law Firm Expands To Include Hemp And CBD

    Vicente Sederberg, one of Colorado's first law firms to focus solely on marijuana, is expanding. Two of the firm's partners were involved in crafting Amendment 64, the proposal to legalize recreational marijuana that Colorado voters approved in 2012, and the firm also had a hand in writing...
  6. Katelyn Baker

    Cannabis Drug Firm GW Pharmaceuticals Taps Wall Street For $252 Million

    Wall Street's strait-laced Republican bankers may have strong personal views on the legalisation of cannabis, but they seem to have no qualms about cashing in on America's marijuana revolution. GW Pharmaceuticals, London's own play on the increasing use of weed for medicinal purposes, has...
  7. Katelyn Baker

    Cannabis Drug Firm GW Pharmaceuticals Taps Wall Street For $252 Million

    Wall Street's strait-laced Republican bankers may have strong personal views on the legalisation of cannabis, but they seem to have no qualms about cashing in on America's marijuana revolution. GW Pharmaceuticals, London's own play on the increasing use of weed for medicinal purposes, has...
Back
Top Bottom